Drug Insights

User-friendly Guide to Find Sodium bicarbonate on Synapse

12 March 2024
2 min read

Sodium bicarbonate, a diminutive molecule drug whose inception into various medical applications has been granted approval since 1981, remains a dynamic treatment option for numerous afflictions, thereby proving its versatile nature. Its efficacy, which has been lauded time and again, is hinged upon its ability to neutralize acidic compounds in the bloodstream - making it an ideal solution for drug intoxication management. That's not all. Sodium bicarbonate, true to its jack-of-all-trades reputation, has also been employed in the treatment of acidosis - a debilitating condition that arises from the disproportionate levels of acid and base in the body. Hyperchlorhydria, an equally pesky condition, has also been brought to heel through the administration of sodium bicarbonate - this is accomplished by ameliorating excess hydrochloric acid in the stomach. Click on the image below to begin the exploration journey of Sodium bicarbonate through the Synapse database!

图形用户界面, 应用程序

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

FDA to Hold Panel Review for Examination of the TRAILBLAZER-ALZ 2 Trial Results on Donanemab
Latest Hotspot
3 min read
FDA to Hold Panel Review for Examination of the TRAILBLAZER-ALZ 2 Trial Results on Donanemab
12 March 2024
Eli Lilly and Company announced that the FDA will convene its Advisory Committee to discuss Phase 3 results of the TRAILBLAZER-ALZ 2 study on the efficacy and safety of donanemab in early Alzheimer's.
Read →
Progress on Amgen's Weight Loss Pipeline: AMG 133
Hot Spotlight
10 min read
Progress on Amgen's Weight Loss Pipeline: AMG 133
12 March 2024
In February, Amgen published a study in Nature Metabolism about AMG 133, a novel molecule with potential for treating obesity.
Read →
Regor Begins Second Stage Trial for Daily Oral GLP-1 Receptor Activator RGT-075 to Combat Excess Weight
Latest Hotspot
3 min read
Regor Begins Second Stage Trial for Daily Oral GLP-1 Receptor Activator RGT-075 to Combat Excess Weight
12 March 2024
Regor Therapeutics Group has announced the launch of its Phase 2 trial on RGT-075, an oral, highly selective GLP-1 receptor agonist.
Read →
Harnessing Synapse for Triamcinolone Information: Strategies and Tips
Drug Insights
2 min read
Harnessing Synapse for Triamcinolone Information: Strategies and Tips
12 March 2024
Triamcinolone, a synthetic corticosteroid, acts as a potent glucocorticoid receptor agonist, mainly used to treat autoimmune diseases such as psoriasis, lupus, and rheumatoid arthritis.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.